The global market for PET Radiopharmaceuticals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PET Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PET Radiopharmaceuticals.

The PET Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global PET Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PET Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of PET Radiopharmaceuticals Market Report

Report Metric	Details
Report Name	PET Radiopharmaceuticals Market
CAGR	5%
Segment by Type	F-18 Ru-82 Others
Segment by Application	Oncology Cardiology Neurology Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), IBA Molecular Imaging (Belgium)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of PET Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of PET Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the PET Radiopharmaceuticals Market report?

Ans: The main players in the PET Radiopharmaceuticals Market are Cardinal Health Inc. (U.S.), Mallinckrodt plc (Ireland), GE Healthcare (U.K.), Lantheus Medical Imaging, Inc. (U.S.), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), IBA Molecular Imaging (Belgium)

What are the Application segmentation covered in the PET Radiopharmaceuticals Market report?

Ans: The Applications covered in the PET Radiopharmaceuticals Market report are Oncology, Cardiology, Neurology, Others

What are the Type segmentation covered in the PET Radiopharmaceuticals Market report?

Ans: The Types covered in the PET Radiopharmaceuticals Market report are F-18, Ru-82, Others

1 PET Radiopharmaceuticals Market Overview

1.1 Product Definition

1.2 PET Radiopharmaceuticals by Type

1.2.1 Global PET Radiopharmaceuticals Market Value Comparison by Type (2024 VS 2031)

1.2.2 F-18

1.2.3 Ru-82

1.2.4 Others

1.3 PET Radiopharmaceuticals by Application

1.3.1 Global PET Radiopharmaceuticals Market Value by Application (2024 VS 2031)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Neurology

1.3.5 Others

1.4 Global PET Radiopharmaceuticals Market Size Estimates and Forecasts

1.4.1 Global PET Radiopharmaceuticals Revenue 2020-2031

1.4.2 Global PET Radiopharmaceuticals Sales 2020-2031

1.4.3 Global PET Radiopharmaceuticals Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 PET Radiopharmaceuticals Market Competition by Manufacturers

2.1 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)

2.2 Global PET Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)

2.3 Global PET Radiopharmaceuticals Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of PET Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of PET Radiopharmaceuticals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of PET Radiopharmaceuticals, Product Type & Application

2.7 Global Key Manufacturers of PET Radiopharmaceuticals, Date of Enter into This Industry

2.8 Global PET Radiopharmaceuticals Market Competitive Situation and Trends

2.8.1 Global PET Radiopharmaceuticals Market Concentration Rate

2.8.2 The Global 5 and 10 Largest PET Radiopharmaceuticals Players Market Share by Revenue

2.8.3 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global PET Radiopharmaceuticals Market Scenario by Region

3.1 Global PET Radiopharmaceuticals Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global PET Radiopharmaceuticals Sales by Region: 2020-2031

3.2.1 Global PET Radiopharmaceuticals Sales by Region: 2020-2025

3.2.2 Global PET Radiopharmaceuticals Sales by Region: 2026-2031

3.3 Global PET Radiopharmaceuticals Revenue by Region: 2020-2031

3.3.1 Global PET Radiopharmaceuticals Revenue by Region: 2020-2025

3.3.2 Global PET Radiopharmaceuticals Revenue by Region: 2026-2031

3.4 North America PET Radiopharmaceuticals Market Facts & Figures by Country

3.4.1 North America PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America PET Radiopharmaceuticals Sales by Country (2020-2031)

3.4.3 North America PET Radiopharmaceuticals Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe PET Radiopharmaceuticals Market Facts & Figures by Country

3.5.1 Europe PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe PET Radiopharmaceuticals Sales by Country (2020-2031)

3.5.3 Europe PET Radiopharmaceuticals Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific PET Radiopharmaceuticals Market Facts & Figures by Region

3.6.1 Asia Pacific PET Radiopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific PET Radiopharmaceuticals Sales by Region (2020-2031)

3.6.3 Asia Pacific PET Radiopharmaceuticals Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America PET Radiopharmaceuticals Market Facts & Figures by Country

3.7.1 Latin America PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America PET Radiopharmaceuticals Sales by Country (2020-2031)

3.7.3 Latin America PET Radiopharmaceuticals Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa PET Radiopharmaceuticals Market Facts & Figures by Country

3.8.1 Middle East and Africa PET Radiopharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa PET Radiopharmaceuticals Sales by Country (2020-2031)

3.8.3 Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global PET Radiopharmaceuticals Sales by Type (2020-2031)

4.1.1 Global PET Radiopharmaceuticals Sales by Type (2020-2025)

4.1.2 Global PET Radiopharmaceuticals Sales by Type (2026-2031)

4.1.3 Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2031)

4.2 Global PET Radiopharmaceuticals Revenue by Type (2020-2031)

4.2.1 Global PET Radiopharmaceuticals Revenue by Type (2020-2025)

4.2.2 Global PET Radiopharmaceuticals Revenue by Type (2026-2031)

4.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2031)

4.3 Global PET Radiopharmaceuticals Price by Type (2020-2031)

5 Segment by Application

5.1 Global PET Radiopharmaceuticals Sales by Application (2020-2031)

5.1.1 Global PET Radiopharmaceuticals Sales by Application (2020-2025)

5.1.2 Global PET Radiopharmaceuticals Sales by Application (2026-2031)

5.1.3 Global PET Radiopharmaceuticals Sales Market Share by Application (2020-2031)

5.2 Global PET Radiopharmaceuticals Revenue by Application (2020-2031)

5.2.1 Global PET Radiopharmaceuticals Revenue by Application (2020-2025)

5.2.2 Global PET Radiopharmaceuticals Revenue by Application (2026-2031)

5.2.3 Global PET Radiopharmaceuticals Revenue Market Share by Application (2020-2031)

5.3 Global PET Radiopharmaceuticals Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Cardinal Health Inc. (U.S.)

6.1.1 Cardinal Health Inc. (U.S.) Company Information

6.1.2 Cardinal Health Inc. (U.S.) Description and Business Overview

6.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio

6.1.5 Cardinal Health Inc. (U.S.) Recent Developments/Updates

6.2 Mallinckrodt plc (Ireland)

6.2.1 Mallinckrodt plc (Ireland) Company Information

6.2.2 Mallinckrodt plc (Ireland) Description and Business Overview

6.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolio

6.2.5 Mallinckrodt plc (Ireland) Recent Developments/Updates

6.3 GE Healthcare (U.K.)

6.3.1 GE Healthcare (U.K.) Company Information

6.3.2 GE Healthcare (U.K.) Description and Business Overview

6.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolio

6.3.5 GE Healthcare (U.K.) Recent Developments/Updates

6.4 Lantheus Medical Imaging, Inc. (U.S.)

6.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information

6.4.2 Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview

6.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolio

6.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates

6.5 Bayer AG (Germany)

6.5.1 Bayer AG (Germany) Company Information

6.5.2 Bayer AG (Germany) Description and Business Overview

6.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolio

6.5.5 Bayer AG (Germany) Recent Developments/Updates

6.6 Bracco Imaging S.p.A (Italy)

6.6.1 Bracco Imaging S.p.A (Italy) Company Information

6.6.2 Bracco Imaging S.p.A (Italy) Description and Business Overview

6.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolio

6.6.5 Bracco Imaging S.p.A (Italy) Recent Developments/Updates

6.7 Eczacibasi-Monrol Nuclear Products (Turkey)

6.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information

6.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview

6.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolio

6.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates

6.8 Nordion, Inc. (Canada)

6.8.1 Nordion, Inc. (Canada) Company Information

6.8.2 Nordion, Inc. (Canada) Description and Business Overview

6.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolio

6.8.5 Nordion, Inc. (Canada) Recent Developments/Updates

6.9 Advanced Accelerator Applications S.A. (France)

6.9.1 Advanced Accelerator Applications S.A. (France) Company Information

6.9.2 Advanced Accelerator Applications S.A. (France) Description and Business Overview

6.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolio

6.9.5 Advanced Accelerator Applications S.A. (France) Recent Developments/Updates

6.10 IBA Molecular Imaging (Belgium)

6.10.1 IBA Molecular Imaging (Belgium) Company Information

6.10.2 IBA Molecular Imaging (Belgium) Description and Business Overview

6.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue and Gross Margin (2020-2025)

6.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolio

6.10.5 IBA Molecular Imaging (Belgium) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 PET Radiopharmaceuticals Industry Chain Analysis

7.2 PET Radiopharmaceuticals Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 PET Radiopharmaceuticals Production Mode & Process Analysis

7.4 PET Radiopharmaceuticals Sales and Marketing

7.4.1 PET Radiopharmaceuticals Sales Channels

7.4.2 PET Radiopharmaceuticals Distributors

7.5 PET Radiopharmaceuticals Customer Analysis

8 PET Radiopharmaceuticals Market Dynamics

8.1 PET Radiopharmaceuticals Industry Trends

8.2 PET Radiopharmaceuticals Market Drivers

8.3 PET Radiopharmaceuticals Market Challenges

8.4 PET Radiopharmaceuticals Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Cardinal Health Inc. (U.S.)

Mallinckrodt plc (Ireland)

GE Healthcare (U.K.)

Lantheus Medical Imaging, Inc. (U.S.)

Bayer AG (Germany)

Bracco Imaging S.p.A (Italy)

Eczacibasi-Monrol Nuclear Products (Turkey)

Nordion, Inc. (Canada)

Advanced Accelerator Applications S.A. (France)

IBA Molecular Imaging (Belgium)

List of Tables

Table 1. Global PET Radiopharmaceuticals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global PET Radiopharmaceuticals Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global PET Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2024

Table 4. Global PET Radiopharmaceuticals Sales (K Pcs) of Key Manufacturers (2020-2025)

Table 5. Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2020-2025)

Table 6. Global PET Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market PET Radiopharmaceuticals Average Price (USD/Pcs) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of PET Radiopharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of PET Radiopharmaceuticals, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of PET Radiopharmaceuticals, Product Type & Application

Table 12. Global Key Manufacturers of PET Radiopharmaceuticals, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PET Radiopharmaceuticals as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global PET Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Pcs)

Table 18. Global PET Radiopharmaceuticals Sales Market Share by Region (2020-2025)

Table 19. Global PET Radiopharmaceuticals Sales by Region (2026-2031) & (K Pcs)

Table 20. Global PET Radiopharmaceuticals Sales Market Share by Region (2026-2031)

Table 21. Global PET Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global PET Radiopharmaceuticals Revenue Market Share by Region (2020-2025)

Table 23. Global PET Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global PET Radiopharmaceuticals Revenue Market Share by Region (2026-2031)

Table 25. North America PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)

Table 27. North America PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Pcs)

Table 28. North America PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)

Table 32. Europe PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Pcs)

Table 33. Europe PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific PET Radiopharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Pcs)

Table 37. Asia Pacific PET Radiopharmaceuticals Sales by Region (2026-2031) & (K Pcs)

Table 38. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)

Table 42. Latin America PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Pcs)

Table 43. Latin America PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa PET Radiopharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)

Table 47. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2026-2031) & (K Pcs)

Table 48. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global PET Radiopharmaceuticals Sales (K Pcs) by Type (2020-2025)

Table 51. Global PET Radiopharmaceuticals Sales (K Pcs) by Type (2026-2031)

Table 52. Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)

Table 53. Global PET Radiopharmaceuticals Sales Market Share by Type (2026-2031)

Table 54. Global PET Radiopharmaceuticals Revenue (US$ Million) by Type (2020-2025)

Table 55. Global PET Radiopharmaceuticals Revenue (US$ Million) by Type (2026-2031)

Table 56. Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)

Table 57. Global PET Radiopharmaceuticals Revenue Market Share by Type (2026-2031)

Table 58. Global PET Radiopharmaceuticals Price (USD/Pcs) by Type (2020-2025)

Table 59. Global PET Radiopharmaceuticals Price (USD/Pcs) by Type (2026-2031)

Table 60. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2020-2025)

Table 61. Global PET Radiopharmaceuticals Sales (K Pcs) by Application (2026-2031)

Table 62. Global PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)

Table 63. Global PET Radiopharmaceuticals Sales Market Share by Application (2026-2031)

Table 64. Global PET Radiopharmaceuticals Revenue (US$ Million) by Application (2020-2025)

Table 65. Global PET Radiopharmaceuticals Revenue (US$ Million) by Application (2026-2031)

Table 66. Global PET Radiopharmaceuticals Revenue Market Share by Application (2020-2025)

Table 67. Global PET Radiopharmaceuticals Revenue Market Share by Application (2026-2031)

Table 68. Global PET Radiopharmaceuticals Price (USD/Pcs) by Application (2020-2025)

Table 69. Global PET Radiopharmaceuticals Price (USD/Pcs) by Application (2026-2031)

Table 70. Cardinal Health Inc. (U.S.) Company Information

Table 71. Cardinal Health Inc. (U.S.) Description and Business Overview

Table 72. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 73. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product

Table 74. Cardinal Health Inc. (U.S.) Recent Developments/Updates

Table 75. Mallinckrodt plc (Ireland) Company Information

Table 76. Mallinckrodt plc (Ireland) Description and Business Overview

Table 77. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 78. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product

Table 79. Mallinckrodt plc (Ireland) Recent Developments/Updates

Table 80. GE Healthcare (U.K.) Company Information

Table 81. GE Healthcare (U.K.) Description and Business Overview

Table 82. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 83. GE Healthcare (U.K.) PET Radiopharmaceuticals Product

Table 84. GE Healthcare (U.K.) Recent Developments/Updates

Table 85. Lantheus Medical Imaging, Inc. (U.S.) Company Information

Table 86. Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview

Table 87. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 88. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product

Table 89. Lantheus Medical Imaging, Inc. (U.S.) Recent Developments/Updates

Table 90. Bayer AG (Germany) Company Information

Table 91. Bayer AG (Germany) Description and Business Overview

Table 92. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 93. Bayer AG (Germany) PET Radiopharmaceuticals Product

Table 94. Bayer AG (Germany) Recent Developments/Updates

Table 95. Bracco Imaging S.p.A (Italy) Company Information

Table 96. Bracco Imaging S.p.A (Italy) Description and Business Overview

Table 97. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 98. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product

Table 99. Bracco Imaging S.p.A (Italy) Recent Developments/Updates

Table 100. Eczacibasi-Monrol Nuclear Products (Turkey) Company Information

Table 101. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview

Table 102. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 103. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product

Table 104. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Developments/Updates

Table 105. Nordion, Inc. (Canada) Company Information

Table 106. Nordion, Inc. (Canada) Description and Business Overview

Table 107. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 108. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product

Table 109. Nordion, Inc. (Canada) Recent Developments/Updates

Table 110. Advanced Accelerator Applications S.A. (France) Company Information

Table 111. Advanced Accelerator Applications S.A. (France) Description and Business Overview

Table 112. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 113. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product

Table 114. Advanced Accelerator Applications S.A. (France) Recent Developments/Updates

Table 115. IBA Molecular Imaging (Belgium) Company Information

Table 116. IBA Molecular Imaging (Belgium) Description and Business Overview

Table 117. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)

Table 118. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product

Table 119. IBA Molecular Imaging (Belgium) Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. PET Radiopharmaceuticals Distributors List

Table 123. PET Radiopharmaceuticals Customers List

Table 124. PET Radiopharmaceuticals Market Trends

Table 125. PET Radiopharmaceuticals Market Drivers

Table 126. PET Radiopharmaceuticals Market Challenges

Table 127. PET Radiopharmaceuticals Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of PET Radiopharmaceuticals

Figure 2. Global PET Radiopharmaceuticals Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global PET Radiopharmaceuticals Market Share by Type: 2024 & 2031

Figure 4. F-18 Product Picture

Figure 5. Ru-82 Product Picture

Figure 6. Others Product Picture

Figure 7. Global PET Radiopharmaceuticals Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global PET Radiopharmaceuticals Market Share by Application: 2024 & 2031

Figure 9. Oncology

Figure 10. Cardiology

Figure 11. Neurology

Figure 12. Others

Figure 13. Global PET Radiopharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global PET Radiopharmaceuticals Market Size (2020-2031) & (US$ Million)

Figure 15. Global PET Radiopharmaceuticals Sales (2020-2031) & (K Pcs)

Figure 16. Global PET Radiopharmaceuticals Average Price (USD/Pcs) & (2020-2031)

Figure 17. PET Radiopharmaceuticals Report Years Considered

Figure 18. PET Radiopharmaceuticals Sales Share by Manufacturers in 2024

Figure 19. Global PET Radiopharmaceuticals Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest PET Radiopharmaceuticals Players: Market Share by Revenue in PET Radiopharmaceuticals in 2024

Figure 21. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global PET Radiopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)

Figure 24. North America PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)

Figure 25. U.S. PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)

Figure 28. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)

Figure 29. Germany PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region (2020-2031)

Figure 36. China PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)

Figure 47. Latin America PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)

Figure 48. Mexico PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Country (2020-2031)

Figure 53. Turkey PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE PET Radiopharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of PET Radiopharmaceuticals by Type (2020-2031)

Figure 57. Global Revenue Market Share of PET Radiopharmaceuticals by Type (2020-2031)

Figure 58. Global PET Radiopharmaceuticals Price (USD/Pcs) by Type (2020-2031)

Figure 59. Global Sales Market Share of PET Radiopharmaceuticals by Application (2020-2031)

Figure 60. Global Revenue Market Share of PET Radiopharmaceuticals by Application (2020-2031)

Figure 61. Global PET Radiopharmaceuticals Price (USD/Pcs) by Application (2020-2031)

Figure 62. PET Radiopharmaceuticals Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-25N19924

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24B19783

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20305

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-12S20176

Mon Nov 24 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global PET Radiopharmaceuticals Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20E7143

Global PET Radiopharmaceuticals Market Research Report 2025

FEATURED COMPANIES

PET Radiopharmaceuticals Market Size

PET Radiopharmaceuticals Market

Report Scope

Scope of PET Radiopharmaceuticals Market Report

Core Chapters

FAQ for this report

Who are the main players in the PET Radiopharmaceuticals Market report?

What are the Application segmentation covered in the PET Radiopharmaceuticals Market report?

What are the Type segmentation covered in the PET Radiopharmaceuticals Market report?

FEATURED COMPANIES

RELATED REPORTS